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Signaling changes that occur in the striatum following the loss of dopamine neurons in the Parkinson disease (PD) are poorly
understood. While increases in the activity of kinases and decreases in the activity of phosphatases have been observed, the
speciﬁc consequences of these changes are less well understood. Phosphatases, such as protein phosphatase 1 (PP1), are highly
promiscuous and obtain substrate selectivity via targeting proteins. Spinophilin is the major PP1-targeting protein enriched in
the postsynaptic density of striatal dendritic spines. Spinophilin association with PP1 is increased concurrent with decreases in
PP1 activity in an animal model of PD. Using proteomic-based approaches, we observed dopamine depletion-induced decreases
in spinophilin binding to multiple protein classes in the striatum. Speciﬁcally, there was a decrease in the association of
spinophilin with neuroﬁlament medium (NF-M) in dopamine-depleted striatum. Using a heterologous cell line, we determined
that spinophilin binding to NF-M required overexpression of the catalytic subunit of protein kinase A and was decreased by
cyclin-dependent protein kinase 5. Functionally, we demonstrate that spinophilin can decrease NF-M phosphorylation. Our
data determine mechanisms that regulate, and putative consequences of, pathological changes in the association of spinophilin
with NF-M that are observed in animal models of PD.
1. Introduction
Proper neuronal communication is essential for normal brain
function. In animal models of Parkinson disease (PD) and in
human PD patients, there is a loss of dopamine (DA) neurons
that project from the substantia nigra to the striatum [1, 2].
These dopamine neurons form synapses with dendritic spines
on striatal medium spiny neurons (MSNs). Loss of DA
signaling leads to decreases in the number of spines on striatal
MSNs [3–5] as well as losses in measures of synaptic plastic-
ity, speciﬁcally long-term depression (LTD) [1, 6]. Changes
in the organization and function of key synaptic proteins that
reside in striatal MSN spines are critical in regulating changes
in spine shape and number as well as LTD [7, 8].
Alterations in kinase and phosphatase activity are
observed in animal models of PD [8–10]. Speciﬁcally, DA
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depletion decreases the activity of protein phosphatase 1
(PP1) in striatal MSNs [8]. Multiple targeting/scaﬀolding
proteins regulate PP1 activity [11–13]. Spinophilin, the most
abundant PP1-associated protein in the PSD [14], targets
PP1 to functionally regulate glutamate receptors [15, 16].
Decreased activity of PP1 in animal models of PD occurs
concurrently with increased association between spinophilin
and PP1 [8]. Spinophilin is known to modulate synaptic plas-
ticity as spinophilin knockout mice do not undergo corticos-
triatal LTD [17]. Moreover, spinophilin has been implicated
as a major hub that interacts with multiple proteins that are
known to be disrupted in neurodegenerative diseases [18];
however, it is not known if spinophilin binding to proteins
in addition to PP1 is altered in the striatum in an animal
model of PD.
We have previously found that multiple intermediate
neuroﬁlamentproteins speciﬁcally coimmunoprecipitatewith
spinophilin [19]. Recent studies demonstrate that neuroﬁla-
ment proteins are found in dendritic spines [20]. Neuroﬁla-
ment medium (NF-M) has been shown to interact with the
DA D1 receptor (D1R) to regulate D1R-mediated behaviors
[20]. Moreover, NF-M is hypophosphorylated in dendritic
spines compared to NF-M in the dendritic shaft, suggesting
that NF-M hyposphosphorylation may be important in
maintaining NF-M in the dendritic spine [20]. Both protein
phosphatases 2A and PP1 have been shown to associate with
and dephosphorylate neuroﬁlament proteins [21]. However,
the roles of scaﬀolding proteins such as spinophilin in
regulating NF-M phosphorylation have never been evaluated.
Here, we have utilized an unbiased, proteomic-based
approach to identify alterations in the spinophilin interac-
tome in the striatum of an animal model of PD and demon-
strate that perturbations in the spinophilin/NF-M interaction
may be due to alterations in kinase activity during DA
depletion. Moreover, we have found that spinophilin can
regulate NF-M phosphorylation in a heterologous cell sys-
tem, and therefore, we predict that spinophilin may be
important in maintaining NF-M in a hypophosphorylated
state in vivo.
2. Materials and Methods
2.1. Generating DNA Constructs. The templates for the con-
structs used were as follows: human spinophilin (REFSEQ:
NM_032595.4)—modiﬁed from Dr. Maria Vivo (University
of Naples “Federico II”); human NF-M (Uniprot ID P07197;
Transomics BC096757-seq); human PKAc—pDONR223-
PRKACA; human CDK5—pDONR223-CDK5; and human
p35—pDONR223-CDK5SR1 were kind gifts from William
Hahn & David Root [22] (plasmid numbers 23495, 23699,
and 23779, Addgene, Cambridge, MA). PCR products were
generated from these template DNAs and inserted into
pDONR221 (ThermoFisher, Waltham MA) for Gateway
cloning into either pcDNA3.1/nV5-DEST (NF-M) or modi-
ﬁed pcDNA3.1/nV5-DEST vectors containing an HA-tag
(spinophilin), myc-tag (PKAc or p35), or FLAG-tag (CDK5)
in place of the V5 tag. Mutant spinophilin (Ser17Ala) or
PKA (Lys72His) constructs were generated using Quick-
Change mutagenesis (Agilent Technologies, Santa Clara,
CA). PCR was performed with Q5 Hot Start TAQ (New
England Biolabs, Ipswich, MA) or VAPRase (Vanderbilt
Antibody Protein Resource, Vanderbilt University, Nashville,
TN). All constructs and mutations were sequence validated
(Genewiz, South Plainﬁeld, NJ).
2.2. Mammalian Cell Protein Expression. Human embryonic
kidney 293FT cells (HEK293; ThermoFisher) were trans-
fected in 25 cm2 ﬂat bottom ﬂasks with each relevant DNA
construct in 500μL serum-free Dulbecco’s modiﬁed Eagle’s
medium (DMEM) using PolyJet reagent (SignaGen Labo-
ratories Rockville, MD) in a 3 : 1 (reagent volume :DNA
mass) ratio. Empty vector DNAs were used to transfect equal
DNA concentrations. Cells were incubated overnight,
medium was aspirated from each ﬂask, and cells were washed
with cold phosphate-buﬀered saline (PBS). HEK293 cells
were then suspended in a low ionic Tris homogenization
buﬀer (0.01M DTT, 0.005M EDTA, 0.002M Tris-HCl pH
7.5, 1% Triton X-100) containing protease inhibitors (HALT;
ThermoFisher) and phosphatase inhibitors (20mM sodium
ﬂuoride, 20mM sodium orthovanadate, 20mM β-glycero-
phosphate, and 10mM sodium pyrophosphate; Sigma-
Aldrich, St. Louis, MO or ThermoFisher).
2.3. Unilateral 6-Hydroxydopamine Lesions. All animal
studies were carried out in accordance with the Guide
for the Care and Use of Laboratory Animals and under the
oversight of either the Vanderbilt University Medical Center
or the Indiana University-Purdue University Indianapolis
Institutional Animal Care and Use Committee. Male C57Bl/
6 mice (Jackson Laboratories, Bar Harbor, ME; ~3 months
of age) were lesioned with 6-hydroxydopamine. Animals
were injected (i.p.) with 7.5mg/kg of desmethylimipramine
(DMI) 15 minutes prior to surgeries. Animals were then
placed in an anesthesia chamber, and isoﬂourane was
administered at a 3% concentration with a ﬂow rate of
~1L/minute. Animals were immobilized in ear bars attached
to a stereotaxic instrument (Leica Biosystems, Buﬀalo Grove,
IL). The top of the head was shaved, and the incision site was
wiped with alcohol then iodine three times. A second injec-
tion of DMI was then given. A 1 cm incision was made, and
the skin was pulled back, exposing the skull. Using a sterilized
drill tip, the skull was drilled at the appropriate coordinates
from Bregma (posterior—2.22mm, lateral—1.66mm) to tar-
get the substantia nigra. The syringe was lowered to the
appropriate depth (ventral—4.7mm). For lesion surgeries,
a total volume of 800nL of 6-hydoxydopamine hydrogen
bromide (Sigma-Aldrich) at a concentration of 6.0μg/μL
(4.0 μg/μL free base) in 0.02% ascorbic acid (Sigma-
Aldrich) in saline was injected at a rate of 40nL/minute.
Following injection and removal of the needle, the incision
was sutured closed. To ensure animal health, 1mL of
warm saline and 5mg/kg (animal weight × 5μL of 1mg/
mL solution) ketoprofen were injected subcutaneously.
Animals were allowed to recover on a warm heating pad.
Mice were sacriﬁced three weeks following lesion and both
lesioned (ipsilateral; experimental) and intact (contralat-
eral; control) striata were harvested.
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2.4. Subcellular Fractionation. Lesioned or intact striatum
was homogenized in a KCl buﬀer (without EDTA) contain-
ing protease and phosphatase inhibitors [23]. An increasing
stringency of detergents was used to fractionate striatal
lysates into a cytosolic, membrane-associated, and synaptic
fraction as previously described [23–25]. Synaptic and
extrasynaptic fractions were utilized for spinophilin immu-
noprecipitations (see below). The cytosolic and membrane
fractions were immunoblotted for TH, and only those
animals with a > 90% reduction in TH immunoreactivity
(indicating eﬃcient lesioning) were used in these studies.
2.5. Immunoprecipitation Assays. HEK293 cell lysate (400–
600μL), whole forebrains, or dissected striatum from adult
male or female wild type C57Bl/6 mice (2.5–9 months old)
were homogenized and sonicated. HEK293 cell lysates were
lysed in a low-ionic Tris buﬀer (0.01M DTT, 0.005M EDTA,
0.002M Tris-HCl pH 7.5, 1% Triton X-100), whereas brain
lysates were generated in a KCl/EDTA buﬀer (150mM KCl,
0.01M DTT, 0.005M EDTA, 0.05M Tris-HCl pH 7.5, 1%
Triton X-100). Both buﬀers contained protease inhibitors
(HALT; ThermoFisher Scientiﬁc) and phosphatase inhibitors
(20mM sodium ﬂuoride, 20mM sodium orthovanadate,
20mM β-glycerophosphate, and 10mM sodium pyrophos-
phate; Sigma-Aldrich or ThermoFisher). Lysates were added
to a microcentrifuge tube with the appropriate primary
antibody (goat spinophilin antibody (SC-14774, Santa Cruz
Biotechnology, Dallas Texas), NF-M antibody (#2383, Cell
Signaling), V5 antibody (#A190-119A Bethyl Laboratories,
Montgomery, TX), HA antibody (#A190-107A Bethyl
Laboratories), PP1γ antibody (SC-6108, Santa Cruz Biotech-
nology), or goat IgG (#005-000-003 Jackson Immunologicals,
West Grove, PA)) and incubated at 4°C for 1 h to overnight.
Protein G magnetic beads were then added to the samples
and incubated 2 h to overnight at 4°C with rotation. Beads
were then washed three times with immunoprecipitation
(IP) buﬀer (150mM NaCl, 50mM Tris-HCl pH 7.5, 0.5%
(v/v) Triton X-100). Washed beads were incubated with
2× Laemmli sample buﬀer, heated at 70°C for 10 minutes,
separated by SDS-PAGE, and immunoblotted.
2.6. Immunoblotting. Immunoblotting was performed as
previously described [26]. Brieﬂy, inputs or immunopre-
cipitates were separated by SDS-PAGE and blotted using
antibodies to spinophilin, NF-M, V5-tag, HA-tag (as above
or rabbit HA (SC-805, Santa Cruz Biotechnology)), PP1γ1,
pan PP1 (SC-7482, Santa Cruz Biotechnology), PKA
substrate antibody (#9624, Cell Signaling), Myc (sc-40, Santa
Cruz Biotechnology), or tyrosine hydroxylase (TH) antibody
(#22941, ImmunoStar, Hudson, WI). Appropriate infrared
secondary antibodies were used (donkey anti-goat, donkey
anti-rabbit, or donkey anti-mouse conjugated to Alexa Fluor
690 or 780; ThermoFisher or Jackson Immunologicals), and
ﬂuorescence intensity measurements were made using Image
Studio (LI-COR Biosciences, Lincoln, NE).
2.7. Mass Spectrometric Analysis. Spinophilin or NF-M
immunoprecipitates were resolved by SDS-PAGE and
stained with colloidal blue or Imperial Stain (ThermoFisher).
Multiple gel regions were excised and processed. Gel
segments were processed using either collisional-induced
dissociation on an Orbitrap Velos mass spectrometer
(ThermoFisher; Vanderbilt University Mass Spectrometry
Research Center; Table S1 available online at https://doi.
org/10.1155/2017/4153076) as previously described [23]
or using higher-energy collisional dissociation (HCD) on
a Q-Exactive mass spectrometer (ThermoFisher; Dr. Lisa
Jones, Department of Chemistry, IUPUI). Conditions for
MS analysis on the Q-Exactive were as follows. Digested
samples were loaded onto a 100μm×2cm Acclaim
PepMap100 C18 nanotrap column (5μm, 100Å) (Thermo-
Fisher) with an Ultimate 3000 liquid chromatograph
(ThermoFisher) at 5μL/min. The peptides were separated
on a silica capillary column that was custom-packed with
C18 reverse phase material (Magic, 0.075mm×150mm,
5μm, 120Å, Michrom Bioresources Inc. Auburn, CA).
The gradient was pumped at 300 nL/min from 10 to 45%
solvent B (99.9% acetonitrile, 0.1% formic acid) for
87min and then to 90% solvent B for 5min and re-
equilibrated to solvent A (99.9% water, 0.1% formic acid)
for 12min. The mass spectrometry was performed on a
Q-Exactive Orbitrap. The mass spectrometer was operated
in data-dependent acquisition mode controlled by the
Xcalibur 2.2 software. Peptide mass spectra were acquired
from an m/z range of 350–2000 at resolving power of
70,000 for 400m/z ions. The top 15 most abundant multiply
charged ions were subjected to higher-energy collisional
dissociation (HCD) at a resolving power of 17,500 for
400m/z ions. Ions with a charge state >+6 were rejected.
AGC targets were set to 3e6 for MS1 and 1e5 for data-
dependent MS2 with an underﬁll ratio of 2.5%, given an
intensity threshold of 5.0e4. A dynamic exclusion of 10.0 s
was used.
2.8. Extracted Ion Chromatogram (XIC) Analysis. CID
MS/MS matching spinophilin peptides containing Ser17
and Ser100 were validated and hand annotated for b- and
y-series ions. Additional spinophilin phosphopeptides were
not consistently detected across all biological replicates.
Accurate mass measurements were used to generate
extracted ion chromatograms (XICs) with a 10-part per
million tolerance. Monoisotopic m/z values of observed
precursor ions (across diﬀerent charge states) were used
to generate XICs. The abundance of each phosphorylated
and nonphosphorylated peptide pair was calculated as
previously described [23], and a ratio was calculated by
dividing the area under the curve (AUC) of the XIC of
the phosphorylated sample by the sum of the AUC of the
XIC of the phosphorylated plus nonphosphorylated sample
(phospho/phospho + total). A ratio of the intact/lesion
sample was then calculated by dividing the individual lesion
value by its corresponding intact value.
CID MS/MS spectra matching NF-M or spinophilin
were hand annotated. The AUCs of XICs for precursor
ions of two speciﬁc tryptic peptides matching NF-M
(QASHAQLGDAYDQEIR and VQSLQDEVAFLR) were
used to compare the abundance of NF-M in the spinophilin
immunoprecipitates isolated from intact and lesioned
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striatal synaptic fractions. AUCs of the XICs for the
NF-M peptides were normalized to an average of the
AUC of the XIC matching 3 spinophilin peptides
(AAGAPQVNSK,VLEESELAR, and SVPAASGGDKEAVAR).
A ratio of the intact/lesion sample was then calculated by
dividing the individual lesion value by its corresponding
intact value.
HCD MS/MS spectra of NF-M phosphopeptides con-
taining Ser30, Ser346, Ser615/620, Ser628/633/641/646/
654/659, Ser680/685, Ser736, and Ser837, were manually
validated, and the AUCs of XICs matching these peptides
were generated (Figure S1A-S1G). These AUCs were
normalized either to the nonphosphorylated peptide or, if
the nonphosphorylated peptide was not detected, to the
nonphosphorylated NF-M peptide EQLQGLNDR. Given
the repeat of certain portions of NF-M, it is not possible to
delineate phosphorylation at speciﬁc sites. Phosphorylation
sites on the detected tryptic peptides are shown in Figure S2.
2.9. Data and Statistical Analyses. A 1-column t-test com-
pared to a theoretical value of 1 was used for statistical anal-
yses comparing two normalized groups. To determine the
eﬀect of CDK5 on wildtype and S17A mutant spinophilin,
the ﬂuorescence intensity for NF-M in the HA (spinophilin)
immunoprecipitate was normalized to ﬂuorescence inten-
sity of spinophilin in the HA IP. To account for any dif-
ferences in NF-M expression, this value was subsequently
divided by the ﬂuorescence intensity for NF-M in the
corresponding input. This is the ﬂuorescence intensity
formula: (coprecipitated protein/precipitated protein)/
(coprecipitated protein in the input). To compare across
multiple gels, a ratio of these normalized values was
created by dividing each value by the wild type, no p35
condition. A two-way ANOVA followed by an uncorrected
Fisher’s least signiﬁcant diﬀerence post hoc test was used to
compare the eﬀect of p35 and S17A genotype on the spino-
philin/NF-M interaction. For all tests, a value of p ≤ 0 05
was considered statistically signiﬁcant. Statistical analyses
and graphing were performed using Prism (GraphPad,
LaJolla, CA). All data are plotted as the mean± the
standard error of the mean. Grubbs outlier tests were
performed on MS data comparing NF-M phosphoryla-
tion in the absence and presence of spinophilin. One outlier
was removed from AKsPVPKsPVEEAK, GKsPVPKsPVEEK,
and AESPVKEEAVAEVVTITK peptides.
3. Results
3.1. Proteomic Identiﬁcation of Spinophilin Interacting
Proteins Isolated from Extrasynaptic and Synaptic Fractions
of the Striatum of 6-Hydroxydopamine Nigral Lesioned Mice.
To model PD, we unilaterally lesioned mouse substantia
nigra using 6-hydroxydopamine (6-OHDA). This kills dopa-
mine neurons that project from the nigra to the striatum.
Striatal tissue from the contralateral, intact hemisphere and
the ipsilateral, lesioned hemisphere was dissected, homoge-
nized, fractionated, and immunoprecipitated as previously
described [23, 24]. Spinophilin immunoprecipitates isolated
from extrasynaptic (S2) or synaptic (S3) fractions were
separated by SDS-PAGE, and gels were Coomassie stained.
The gel regions containing spinophilin (Figure 1(a); red
boxes) or associated proteins (Figure 1(a); black boxes) were
excised, digested with trypsin, and processed by mass
spectrometry to identify, de novo, spinophilin interacting
proteins isolated from intact and lesioned striatum (see
Section 2). We only used animals that had at least a
90% depletion of TH by immunoblotting (Figure 1(b)).
There was little diﬀerence in total protein levels as
evidenced by Ponceau staining (Figure 1(b)). Across 6
biological replicates (3 biological replicates analyzed on
two separate days), we identiﬁed 125 total proteins that
contained at least 48 spectral counts (an average of at least
2 spectral counts per sample across all 24 samples (lesion/
intact; S2/S3); Table S1).
3.2. Spinophilin Interactions Are Modulated in Animal
Models of PD. In order to understand how dopamine deple-
tion may regulate spinophilin interactions on a global scale,
we utilized state-of-the-art proteomic approaches to quantify
proteins in the spinophilin immunoprecipitates in the stria-
tum of intact or lesion animals. As a proof of this approach,
we found that spinophilin had an increased association
(~28%) with PP1 in the S3 fraction of the lesioned hemi-
sphere. These results corroborate studies that we have previ-
ously performed in rats using immunoblotting approaches
[8]. In addition to PP1, proteomic-based approaches allow
us to identify changes without any a priori knowledge of
the interaction. Using these approaches, to quantify spino-
philin interactions, the total number of spinophilin-
associated protein spectral counts from the intact and
lesioned samples was normalized to the total number of
spinophilin spectral counts in the same fraction and treat-
ment. We then divided the normalized spectral count ratio
of the lesion sample by that of the intact sample to generate a
normalized lesion/intact ratio for each protein in the S2
and S3 fraction (Table S1). Using STRING database [27],
we analyzed those proteins that had at least 50 spectral
counts in either the S2 or S3 fraction and that had a nor-
malized increase or decrease of 18%. This value was based
on the decrease in NF-M protein isolated from spinophilin
immunoprecipitates in lesion compared to intact striatum
(see below). In the S3 fraction, 45 proteins had a decreased
association with spinophilin, whereas 15 proteins had an
increased association with spinophilin in the lesioned
compared to intact hemisphere. In the S2 fraction, the
number of increased and decreased associations was simi-
lar, 15 and 17 proteins, respectively. In both fractions, we
observed decreases in the association of spinophilin with
multiple cytoskeletal and synaptic signaling and scaﬀold-
ing proteins in the lesioned compared to intact striatum
(Figures 1(c) and 1(d)). Moreover, in the synaptic
fraction of lesioned animals, we observed a decreased
association of spinophilin with vesicle-traﬃcking proteins,
ATPases, GTPases, and other protein classes (Figure 1(e)).
In addition, we observed more myosin proteins and
basement membrane proteins associating with spinophilin
in the S3 fraction after lesioning (Figure 1(f)). In the S2
fraction, we observed an increase in the association of
4 Neural Plasticity
200
116
97
66
45
31
IgGH
IgGL
Coomassie
Intact Lesion
Spinophilin 
immunoprecipitation
WB: tyrosine 
hydroxylase
Intact Lesion
Ponceau S.
total protein stain
(a) (b)
Dlgap3 Atp6v0a1Camk2a Ap2a1Syngap1
Dlgap2 Fbxo41
Grin1Camk2b Anxa2
Jup
Actn1
Myo1b
Tuba1b
Synpo
Postsynaptic signaling 
and scaffolding
Cytoskeletal
Bsn Cntn1 Kcnma1
Ctnna2
Pclo Cltc
Kiaa1468 Srpk2
Dlg4
Pygm
Rplp0
Iqsec1
Matr3
InaAgap2
Mtap6
Tubb5
Vesicle 
trafficking
Cell adhesion
Cytoskeletal
GTP 
function
(c) S2 decreased (d) S2 increased
Dpysl2 Tuba1aDnm1 Ap2b1 Tubb5Myo1b
Ap2a1
Spnb2
Spna2CltcAp2a2
Plec
Syn1Stxbp1 Epb4.1l3
Tuba1bActn1Dbn1 Nefm
Mtap6
Agap2
Cntn1
Grin1
Shank3
Gnao1
Ncam1 Camk2b
Iqsec1
Dlgap3
Dlgap2
Atp1a3
Atp1a1
Atp2b2
Hspa8
Atp1a2Hsp90b1 Atp2a2
Atp6v0a1Hk1
Aco2
Cnp
Plp1
GapdhCpne5 Uba1
Vesicle trafficking
Cell adhesion
Chaperone
Cytoskeletal
GTP function
Postsynaptic signaling
and scaffolding
ATPases
Metabolism
Lipid/myelin
Ppp1ca
Actb
Myh9
Gfap
Myo1d Ina
Myh11
Lamb2 Lamc1
Nid1Hist1h1d
Hspg2
Dlg2
Fbxo41 Nid2
Cytoskeletal Basement membrane
Nuclear
(e) S3 decreased (f) S3 increased
Figure 1: STRING map of proteins with altered expression in spinophilin immunoprecipitates isolated from DA lesioned compared to intact striatal
lysates. The substantia nigra of adult C57Bl6 mice was unilaterally lesioned with 6-OHDA. Striata from the intact and lesioned hemispheres were
collected, fractionated into a membrane and synaptic fraction, and immunoprecipitated for spinophilin using a goat spinophilin antibody. (a) The
regions of the gel containing spinophilin and NF-M (red boxes) and spinophilin interacting proteins (black boxes) were excised and analyzed by
mass spectrometry. (b) Striatal lysates from the intact (I) and lesioned (L) hemispheres were stained for a total protein stain (Ponceau S) and
subsequently immunoblotted for tyrosine hydroxylase. The Uniprot ID for proteins detected in spinophilin immunoprecipitates that had a >18%
decrease or increase in spectral counts isolated from either the extrasynaptic (c and d, respectively) or synaptic (e and f, respectively) fractions was
inputted into the string database (http://www.string-db.org) to demonstrate connectivity between proteins. Proteins were assigned to categories based
on protein function. The gene names for the proteins are used as identiﬁers.Mass spectrometry was performed on anOrbitrapVelosmass spectrometer.
5Neural Plasticity
spinophilin with vesicle-traﬃcking proteins, such as clathrin,
and cell adhesion proteins, such as contactin (Figure 1(d)).
3.3. NF-M Is Decreased in Spinophilin IPs after 6-OHDA
Lesion. Recent studies have found that neuroﬁlament
medium is localized to dendritic spines and is hypopho-
sphorylated in the spines [20]. This makes it an interesting
candidate for validation of the spectral counting data.
Initial spectral counting data suggested that the
spinophilin/NF-M interaction was decreased in the stria-
tum of 6-OHDA-lesioned mice. To further conﬁrm this
decrease, the proteomic data from above were further ana-
lyzed. Speciﬁcally, the AUC of the XIC of two unique pep-
tides (Figures 2(a) and 2(c)) on NF-M were quantiﬁed and
normalized to the average AUC of three peptides matching
spinophilin in the spinophilin IPs. We observed a decrease
in NF-M in the spinophilin immunoprecipitates isolated
from the striatum of the lesioned mice (Figures 2(b) and
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Figure 2: Reduced AUC of XICs matching NF-M in spinophilin immunoprecipitates isolated from the synaptic fraction of DA depleted
striatum. MS/MS spectra matching the NF-M peptides QASHAQLGDAYDQEIR (a) and VQSLQDEVAFLR (c). The AUCs of the XIC
matching the above peptides were normalized to relative levels (AUC of the XIC) of the average of 3 spinophilin peptides. These
normalized values were divided by the corresponding value from the intact sample to generate a normalized ratio. The normalized ratios
for QASHAQLGDAYDQEIR (b) and VQSLQDEVAFLR (d) are plotted. ∗∗p ≤ 0 01. N = 6/group. Mass spectrometry was performed on
an Orbitrap Velos mass spectrometer.
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2(d) ∗∗p ≤ 0 01). This decrease was not due to any potential
changes in spinophilin levels, as we normalized the AUC of
the XIC to an average of the AUC of 3 spinophilin XICs.
These data demonstrate that 6-OHDA lesion decreased the
association of spinophilin with NF-M.
3.4. NF-M Coimmunoprecipitates with Spinophilin and PP1.
We previously found that NF-M was enriched in spino-
philin immunoprecipitates isolated from wild type, but
not knockout forebrain lysates using proteomic-based
approaches [19]. To conﬁrm speciﬁcity, we performed spino-
philin immunoprecipitation and immunoblotted for NF-M
isolated from mouse striatum. While NF-M and spinophilin
associated in the striatum, we did not observe spinophilin
in the NF-M IPs (Figures 3(a), 3(b)). Spinophilin [28, 29],
but not NF-M [30], directly interacts with PP1. However,
NF-M may associate with PP1 indirectly. Consistent with
an association of PP1 with NF-M in an in vivo context,
NF-M was detected in PP1 immunoprecipitates from the
striatum (Figure 3(b)).
3.5. Nigral 6-Hydroxydopamine Lesion Increases Striatal
Spinophilin Phosphorylation at Ser17 and Ser100. The
mechanisms by which the association between spinophilin
and synaptic proteins such as NF-M may be modulated
following DA depletion are not known. Spinophilin phos-
phorylation has been shown to decrease spinophilin binding
to F-actin and the alpha-2 adrenergic receptor [31–33].
Therefore, we evaluated spinophilin phosphorylation in our
lesion and intact striatal spinophilin IPs. Using AUC of
speciﬁc XICs that have MS/MS spectra that match spinophi-
lin tryptic peptides phosphorylated at Ser17 and Ser100
(Figures 4(a) and 4(c), respectively), we found that spinophi-
lin phosphorylation at both Ser17 and Ser100 was increased
by 6-OHDA lesioning (Figures 4(b) and 4(d); ∗p ≤ 0 05).
Therefore, enhanced kinase activity and subsequent increases
in spinophilin phosphorylation are putative mechanism(s)
for the observed decreased association of this scaﬀolding
protein with multiple synaptic proteins, such as NF-M.
3.6. The Interaction of Spinophilin and NF-M in HEK293
Cells Requires Overexpression of the PKA Catalytic Subunit.
As spinophilin phosphorylation was regulated by DA
depletion, we wanted to further determine if kinases can
regulate the spinophilin/NF-M interaction. While there
was little basal association between spinophilin and NF-
M in a heterologous HEK293 cell line, upon overexpres-
sion of the catalytic subunit of PKA (PKAc), there was a
robust and speciﬁc association between spinophilin and
NF-M (Figure 5(a)). To determine if kinase activity was
required for this interaction, we overexpressed a kinase
dead mutant of PKA (K72H) [34]. There was no associa-
tion of spinophilin with NF-M when the K72H mutant
of PKA was expressed, indicating that this interaction
was phosphorylation-dependent (Figure 5(b)). Spinophilin
associated with both the wild type and the K72H PKAc
(Figure 5(b)); however, there was an approximate 63%
reduction in the association of spinophilin with the
mutant PKAc (Figure 5(c); N = 3; p = 0 0546), suggesting
that mutation of PKAc attenuates spinophilin binding to
the kinase. Moreover, while PKAc was detected in the
NF-M IPs (Figure 5(d)), the levels were low in some
experiments and undetectable in others.
3.7. CDK5 Attenuates Spinophilin/NF-M Interaction. In
addition to PKA, spinophilin is phosphorylated by CDK5
at Ser17. This phosphorylation was also enhanced in an
animal model of PD (Figure 4(b)), further suggesting that
CDK5 activity is increased by DA depletion [35, 36]. Using a
heterologous cell model, we transfected spinophilin, NF-M,
and PKAc in the absence or presence of CDK5 and its
activator p35. Active CDK5 decreased the association
between spinophilin and NF-M. This decrease occurred
concurrently with decreased expression of NF-M and
PKAc (Figure 6(a)). Overexpression of p35 alone decreased
the association between spinophilin and NF-M without
modulating NF-M or PKA expression (Figure 6(b); p35
expression ANOVA value F(1, 26) = 11.47; P = 0 0023). The
p35-induced decreased association between spinophilin
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Figure 3: NF-M coimmunoprecipitates with spinophilin and PP1 in the mouse brain. Spinophilin (goat antibody), NF-M (mouse antibody),
and the γ1 isoform of protein phosphatase 1 (PP1γ1; goat antibody) were immunoprecipitated fromwild type mouse cortical (a) or striatal (b)
tissue lysates homogenized in isotonic KCl buﬀer and immunoprecipitated with a goat antibody against spinophilin.
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and NF-M was not due to spinophilin phosphorylation at
Ser17, as mutation of this site had no eﬀect on spinophilin
binding to NF-M (Figure 6(b); genotype ANOVA value
F(1,26) = 0.2494; P = 0 6217). Moreover, there was no
interaction between genotype and p35 expression
(F(1,26) = 0.2490; P = 0 6220). Post hoc analysis found a
signiﬁcant diﬀerence between the p35 conditions for the
wild type spinophilin (p = 0 0086; N = 7‐8) and a trend
for a decrease between these two conditions for the S17A
mutant (p = 0 0587; N = 7‐8).
3.8. Spinophilin Regulates NF-M Phosphorylation State.
To determine the putative implications of modulating
the spinophilin/NF-M association, we evaluated the
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Figure 4: Synaptic spinophilin phosphorylation at Ser17 and Ser100 is enhanced by DA depletion. The substantia nigra of adult C57Bl6 mice
was unilaterally lesioned with 6-OHDA. Striata from the intact and lesioned hemispheres were collected, fractionated into a membrane and
synaptic fraction, and immunoprecipitated for spinophilin as in Figure 1. The region of the gel containing spinophilin and NF-M (Figure 1(a))
was excised and analyzed by mass spectrometry. (a) MS/MS spectra of a spinophilin tryptic fragment containing phosphorylated Ser17. (b)
Quantiﬁcation of the normalized AUC of the XICmatching the Ser17 in lesion and intact tissue normalized to the corresponding intact value.
(c) MS/MS spectra of a spinophilin tryptic fragment containing phosphorylated Ser100. (d) Quantiﬁcation of the normalized AUC of the XIC
matching the Ser100 in lesion and intact tissue normalized to the corresponding intact value. ∗p ≤ 0 05 compared to the intact group.
N = 6/group. Mass spectrometry was performed on an Orbitrap Velos mass spectrometer.
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phosphorylation status of NF-M overexpressed in HEK293
cells in the absence or presence of overexpressed spinophi-
lin. Using MS-based approaches, we detected NF-M tryptic
peptides that had a single phosphorylation site at residues
Ser346, Ser736, and Ser837. In addition, we detected
phosphorylation of the second serine in the repeated
peptide, SPVPKSPVEEK, corresponding to Ser620, Ser633,
Ser646, and/or Ser659. In the KSP repeat domain, phos-
phorylation of the ﬁrst serine on these repeat peptides
may prevent cleavage of the lysine prior to the ﬁrst
serine. We detected doubly phosphorylated peptides
matching the following tryptic peptides and residues:
AKSPVPKSPVEEK, doubly phosphorylated at 615 and
620; GKSPVPKSPVEEK, doubly phosphorylated at Ser 628
and Ser633, Ser641 and Ser646, and/or Ser654 and Ser659;
and AKSPVPKSPVEEAK, doubly phosphorylated at Ser
680 and Ser685. The MS/MS spectra were validated
and hand annotated (Figures S1A–S1G). Phosphorylation
of the peptides QLS(PO4)DIEER, SPVPKS(PO4)PVEEK,
and AES(PO4)PVKEEAVAEVVTITK was unchanged by
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Figure 5: PKA overexpression is required for the spinophilin/NF-M interaction. (a) HEK293 cells were transfected with HA-tagged
spinophilin, V5-tagged NF-M, and/or Myc-tagged PKAc. HA (goat antibody) immunoprecipitates were immunoblotted for HA (rabbit
antibody), NF-M (mouse antibody), and Myc (mouse antibody). Data are representative of 3 independent experiments. (b, c) HEK293
cells were transfected with HA-tagged spinophilin, V5-tagged NF-M, and/or wild type or kinase dead (K72H mutant (MT)) myc-tagged
PKAc. HA (goat antibody) (b) or V5 (rabbit antibody) (d) immunoprecipitates were immunoblotted for HA (rabbit antibody), NF-M
(mouse antibody), and/or Myc (mouse antibody). (c) Decrease in the association of mutant compared to wild type PKA in the spinophilin
immunoprecipitates (p = 0 0546, n = 3).
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spinophilin overexpression (Figures 7(a), 7(b), and 7(f));
however, NF-M phosphorylation at Ser837 and at all of
the doubly phosphorylated residues in the KSP repeat
region was reduced by coexpression of spinophilin
(Figures 7(c), 7(d), 7(e), and 7(g)). These studies were per-
formed in the absence of overexpressed PKAc, suggesting
that even though the association between spinophilin and
NF-M is somewhat transient under these conditions, spi-
nophilin can functionally modulate NF-M phosphorylation
even in the absence of PKAc.
4. Discussion
4.1. 6-OHDA Lesioning Modulates Spinophilin Interactions
and the Phosphorylation State of Spinophilin. Loss of stria-
tal DA is associated with decreased dendritic spine density
in the striatum, as well as loss of molecular correlates of
learning and memory, such as LTD [1–5]. Spinophilin
modulates dendritic spine density and regulates LTD
[17, 37–39]. Spinophilin is known to associate with
and modulate the function of multiple synaptic proteins
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Figure 6: CDK5 activity attenuates the spinophilin/NF-M interaction. (a) HEK293 cells were transfected with spinophilin, NF-M, PKAc,
p35, and/or CDK5. HEK293 cell lysates and HA (spinophilin) immunoprecipitates were immunoblotted for NF-M, Myc tag (PKA or
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[19, 26, 39–42]. We found that unilateral lesioning of the
nigra of mice with 6-OHDA signiﬁcantly increases phos-
phorylation of spinophilin at Ser17 and Ser100 in mouse stri-
atum. Previous studies have demonstrated that spinophilin
phosphorylation by PKA, CaMKII, and/or ERK attenuate
its association with F-actin [31, 32, 43]. Concurrent with this
altered spinophilin phosphorylation, we observed increases
in the association of spinophilin with PP1, recapitulating
what was previously found in rats [8]. While it may appear
counterintuitive that greater association of spinophilin
with PP1 reduces PP1 activity, previous studies have found
that while spinophilin is important in targeting PP1 to
various substrates, it also may inhibit its activity towards
speciﬁc substrates [13]. This inhibition is substrate selective;
therefore, tighter binding may aﬀect some substrates but
not others. Therefore, reduced PP1 activity in the context of
greater kinase activity (such as CaMKII) [9, 10] may tip the
balance towards phosphorylation. In addition to the
increased association of spinophilin with PP1, we observed
a decreased association of spinophilin with multiple synaptic
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Figure 7: Spinophilin regulates NF-M phosphorylation. NF-M was overexpressed in HEK293 cells in the absence or presence of
overexpressed spinophilin. V5 (rabbit antibody) immunoprecipitates were subjected to MS/MS analysis, and phosphorylation sites
were quantiﬁed and normalized to the corresponding no spinophilin condition. (a–g) The ratios of phosphorylation for 7 speciﬁc
phosphorylated tryptic peptides are shown. ∗∗∗p ≤ 0 001; ∗∗∗∗p ≤ 0 0001 compared to no spinophilin transfection. N = 5–7/group.
Mass spectrometry was performed on a Q-exactive mass spectrometer.
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proteins, including synaptic signaling and scaﬀolding
proteins (e.g., GluN1 and SAPAP3) and cytoskeletal proteins
(e.g., NF-M). Therefore, increased PP1 interaction with
spinophilin along with decreased spinophilin association
with synaptic proteins may both lead to decreased synaptic
protein phosphorylation.
4.2. Mechanisms Regulating Spinophilin/NF-M Interaction.
We detected NF-M in spinophilin immunoprecipitates
isolated from striatal or forebrain lysates. We previously
observed that this interaction was speciﬁc as NF-M had
fewer spectral counts in spinophilin immunoprecipitates
isolated from spinophilin knockout compared to wild
type mice [19]. Moreover, we detected both spinophilin
and NF-M in PP1 immunoprecipitates from striatal
lysates; however, we did not detect spinophilin in NF-M
immunoprecipitates. This may be due to occlusion of the
NF-M antibody-binding site when spinophilin is bound,
or it could be due to few spinophilin molecules bound
to multiple NF-M molecules. In the latter scenario, when
spinophilin is immunoprecipitated, it can extract multiple
NF-M molecules, whereas immunoprecipitating multiple
NF-M molecules would only extract a few (below the limit
of detection) spinophilin molecules. When both spinophi-
lin and NF-M were overexpressed in HEK293 cells in
the presence of PKAc, there was a robust and speciﬁc
interaction between the two proteins. As in the brain
lysates, we only detected NF-M in the spinophilin immu-
noprecipitates and we did not detect spinophilin in the
NF-M immunoprecipitates (data not shown). However,
in the HEK293 cell experiments, we used tag antibodies,
further validating the association and suggesting that
antibody-site occlusion is not responsible for our inability
to visualize spinophilin in NF-M immunoprecipitates, but
rather, this may be due to few spinophilin molecules
bound to multiple NF-M molecules, as described above.
In order to determine if kinase activity was required for
regulating the association between spinophilin and NF-M,
we used a K72H kinase dead mutant of PKAc [34]. We found
that the association between spinophilin and NF-M was not
enhanced by this mutant form of PKAc. This ﬁnding suggests
that catalytic activity of the kinase is required for the interac-
tion between spinophilin and NF-M. However, an alternative
interpretation may be that the mutant form of PKAc cannot
act as a bridge between the two proteins. Interestingly, the
association of spinophilin with the mutant PKA was
decreased by 63% compared to spinophilin binding to the
wild type PKAc. However, both wild type and K72H forms
of PKAc did not consistently bind to NF-M. This lack of con-
sistent binding to NF-M argues against the bridge hypothesis;
however, we cannot completely rule out that PKAc overex-
pression may be acting as a bridge to stabilize the association
between spinophilin and NF-M.
Both spinophilin [32] and NF-M [44] are phosphory-
lated by PKA. Improper phosphorylation of neuroﬁla-
ments can aﬀect dendritic structure due to improper
transport and cross-bridging of these proteins. Moreover,
phosphorylation of neuroﬁlament proteins can also impact
their association with other proteins [45–47]. As stated
above, we did not detect spinophilin in NF-M immuno-
precipitates; therefore, it is also possible that PKA is
enhancing the bridging of NF-M monomers and that there
are more NF-M molecules associated with a single spino-
philin molecule. Given the increased interaction between
NF-M and spinophilin in HEK293 cells upon overexpres-
sion of PKA, increased phosphorylation of spinophilin
and/or NF-M by PKA is most likely not contributing to
the decreased interaction between spinophilin and NF-M
that we observed in animal models of PD. We have uti-
lized a heterologous cell system to explain changes in the
spinophilin/NF-M interaction that are observed in an ani-
mal model of PD. It is important to reiterate that a heter-
ologous cell system does not completely recapitulate what
is observed in a neuron. Moreover, even the observed
changes in dopamine-depleted animals have caveats. Spe-
ciﬁcally, it is important to note that our studies evaluate
global changes in the spinophilin interactome. Given that
the striatal MSNs are subdivided into direct and indirect
pathway neurons and that the direct pathway neurons
would be predicted to have less PKA-dependent activation
(as DA D1 receptors activate PKA) upon loss of DA, there
may be cell-speciﬁc diﬀerences in the activation of PKA.
Previous studies have shown that NF-M interacts with
the DA D1 receptor [20, 48]. This may suggest that NF-
M localization may be diﬀerent in the two MSN pathways;
however, to our knowledge, this has not been tested.
Therefore, spinophilin phosphorylation and/or interactions
may be diﬀerentially modulated in the two MSN cell types
(Figure 8). Future studies will need to address if there are
cell-speciﬁc dopamine depletion- and/or PKA activity-
induced changes that contribute to the decreased associa-
tion between spinophilin and NF-M.
In addition to increased phosphorylation of spinophilin
at a PKA site in lesioned striatum, we observed augmented
phosphorylation of spinophilin at a CDK5 site. Therefore,
we next determined the functional role of CDK activity in
modulating the association between spinophilin and NF-M
in the context of PKA overexpression. Converse to the eﬀect
of PKA overexpression, overexpression of CDK5 and its
activator, p35, decreased the association between spinophi-
lin and NF-M as well as the expression of NF-M. CDK5-
dependent regulation of NF-M expression is consistent
with studies suggesting that downregulation of CDK5/p35
enhances neuroﬁlament heavy expression [49]. It is impor-
tant to note that expression of the neuroﬁlament protein,
neuroﬁlament heavy, in the striatum is increased following
short-term (3 days) 6-OHDA lesion of the nigra but is
decreased following longer-term (14 days) depletion [50].
Moreover, CDK5 phosphorylates NF-M [51], and this
was also apparent in our data, given a dramatic molecular
weight shift in the NF-M band following CDK5 overex-
pression. Overexpression of the CDK5 activator, p35,
alone had no obvious eﬀects on NF-M expression; how-
ever, activation of endogenous CDK5 was suﬃcient to
decrease the association between spinophilin and NF-M.
While we observed increased phosphorylation of spinophi-
lin at Ser17, a CDK5 site, in animal models of PD, it does
not appear that increased phosphorylation at this site is
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responsible for the alterations in the spinophilin/NF-M
association, as mutation of this site to an alanine did not
rescue CDK5 activity-dependent decreases in the interac-
tion between spinophilin and NF-M. Therefore, our data
suggest that phosphorylation of NF-M, and/or an additional
bridging protein, may be responsible for the CDK5-
dependent decreases in the spinophilin/NF-M interaction.
Unfortunately, NF-M is phosphorylated by CDK5 at
multiple sites in the KSP repeat domain, making it diﬃcult
to determine if phosphorylation of NF-M is critical for regu-
lating this interaction.
As stated above, spinophilin phosphorylation and inter-
actions may be diﬀerentially regulated in the two MSN cell
types. For instance, dopamine depletion using an MPTP
model led to increases in CDK5 phosphorylation at a site that
enhances CDK5 activity [36]. Interestingly, phosphorylation
at this site is controlled by D2 DA receptor activity [36].
Therefore, taken together with the PKA data, we propose
a model that changes in spinophilin phosphorylation
and/or interactions may be diﬀerent in the two MSN cell
types. Moreover, given that there may be a greater eﬀect
of dopamine depletion on modulating indirect pathway
MSNs [52, 53], these changes may predominate. Also, given
that CDK5 activation, even in the presence of overexpressed
PKA, led to dramatic reductions in the spinophilin/NF-M
interaction, we speculate that CDK5 activity can attenuate
any PKA-dependent increases that are observed. We propose
a model whereby spinophilin phosphorylation and associa-
tion with NF-M may be altered in the two MSN cell types
by dopamine depletion (Figure 8). It is currently unclear if
some of the pathological changes, including loss of den-
dritic spines, occur only in the indirect pathway MSNs
[52] or if the loss of spines occurs in both pathways
[2, 4, 5, 54, 55]. However, it is known that signaling
and other proteins have diﬀerential expression and/or
function in the two MSN pathways [56–58].
4.3. Spinophilin Regulates NF-M Phosphorylation at Speciﬁc
Residues: Implications in Neurodegeneration. Spinophilin is
important in targeting PP1 to multiple substrates to decrease
their phosphorylation. However, as stated above, spinophilin
can also inhibit PP1 activity towards certain substrates [13].
Therefore, we wanted to determine the putative functional
consequences of altering the spinophilin/NF-M association
on NF-M phosphorylation. Overexpression of spinophilin
in HEK293 cells reduced NF-M phosphorylation on multiple
tryptic fragments. Previous mass spectrometry studies have
shown that the KSP repeat region in bovine neuroﬁlament
proteins is highly phosphorylated [47]. Similar to spino-
philin, NF-M is also located in dendritic spines. Moreover,
levels of phosphorylated NF-M are lower in these synaptic
locations compared to other regions [20]. Overexpression
of spinophilin reduces NF-M phosphorylation in the KSP
repeat domain in HEK293 cells. In addition to this region,
spinophilin reduced NF-M phosphorylation at Ser837. Using
a global proteomic analysis, previous reports show that
Ser837 on NF-M is phosphorylated in human embryonic
stem cells [59]. Moreover, Ser837 has been shown to be
hyperphosphorylated in Alzheimer’s disease postmortem
samples [60]. Together, these data demonstrate that
spinophilin can modulate NF-M phosphorylation in a
heterologous cell system. We propose that mechanisms
similar to this may be important in maintaining NF-M in a
dephosphorylated state in the dendritic spine and future
studies will need to delineate this role of spinophilin in vivo.
4.4. Conclusions. Understanding putative mechanisms by
which NF-M phosphorylation in dendritic spines is regulated
is of great interest, as dendritic spine density is decreased in
PD [3–5] and these neuroﬁlament proteins play a structural
role in dendritic spines. Here, we demonstrate that spinophi-
lin associates with NF-M in brain lysates. Furthermore, we
show that in a heterologous cell system, this association is
regulated by kinase activity/expression and that spinophilin
overexpression reduces NF-M phosphorylation at several
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Figure 8: Hypothesis of how loss of DA may cell-speciﬁcally
modulate the spinophilin/NF-M association and the putative
in vivo functional consequences of altering this interaction. (1)
Following loss of DA, DA D2 receptors (top) or D1 receptors
(bottom) are no longer activated by DA. This leads to (2) increases
in PKA and CDK5 activity in the indirect pathway MSNs (top) and
decreases in PKA activity in the direct pathway MSNs (bottom).
CDK5 activation overwhelms any increases in PKA activation
observed in the indirect pathway MSNs. Both decreased PKA
activity and increased CDK5 activation lead to (3) decreased
association of spinophilin with NF-M and less PP1 targeting by
spinophilin, which causes (4) increased phosphorylation of NF-M
and (5) loss of NF-M in the dendritic spine.
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residues in the KSP repeat domain. Our data show that the
NF-M/spinophilin interaction is decreased in an animal
model of PD and that spinophilin can decrease NF-M phos-
phorylation. In addition to NF-M, our proteomic data have
identiﬁed other synaptic spinophilin interacting proteins
that are modulated by DA depletion, contributing to the
hypothesis that spinophilin may be an important “hub”
protein in PD [18]. Understanding how spinophilin
modulates the phosphorylation status of these substrates
in vivo and in speciﬁc cell types and how perturbations
in spinophilin interactions contribute to pathological
changes in striatal MSN spine density associated with PD
will greatly enhance our understanding of the pathophysi-
ology of this disorder.
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